How much does ofatumumab cost?

Ofatumumab, trade name Kesimpta, is available as a 20 mg injection, prefilled in a syringe/pen, and is indicated for the treatment of relapsing forms of multiple sclerosis in adults. The recommended dose for patients is 2 0mg ofatumumab, administered by subcutaneous injection and administered monthly after loading, its treatment has been shown to rapidly depleteB cells, thereby contributing to the onset of multiple sclerosis by affecting and regulating different autoimmune processes, such as T cell production and APC activity.

Ofatumumab with the trade name ofArzerrais available100mg or 1000mg concentrated infusion, suitable for the treatment of untreated, relapsed or refractory chronic lymphoma For chronic lymphocytic leukemia (CLL), the recommended dose for the treatment of chronic lymphocytic leukemia is higher than that for multiple sclerosis, with a monthly infusion of 1000 or 2000 mg depending on whether the chronic lymphocytic leukemia is untreated, relapsed or refractory after loading. Ofatumumab is being studied as a potential treatment for follicular lymphoma, diffuse large B-cell lymphoma and rheumatoid arthritis.

The original drug of ofatumumab has been launched in China and has also been included in medical insurance. Only patients who meet the indications can be reimbursed. The price is around tens of thousands of yuan, and domestic purchase channels are relatively difficult. The European version of ofatumumab original drug specifications20mg/0.4mL each sold overseas may cost around RMB 16,000 (the price may fluctuate due to the exchange rate). It is expensive and there are currently no generics of ofatumumab. For more drug information and specific prices, please consult a medical consultant.